Bcal Diagnostics

(ASX) BDX

Current Price$0.08

Market Cap$30.60M

Since IPO (2021)-67%

5 YearN/A

1 Year+4%

1 Month-10%

Bcal Diagnostics Financials at a Glance

Market Cap

$30.60M

Revenue (TTM)

$3.88M

Net Income (TTM)

$15.15M

EPS (TTM)

$-0.02

P/E Ratio

-4.23

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.08

Volume

160

Open

$0.08

Price

$0.08

Volume

160

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.08

52-Week Range

$0.05 - $0.15

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.08

Volume

160

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.08

52-Week Range

$0.05 - $0.15

BDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bcal Diagnostics

Industry

Biotechnology

Sector

Health Care

CEO

Shane Ryan

Website

www.bcaldiagnostics.com

Headquarters

Sydney, NSW 2000, AU

BDX Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

-6%

Net Income Margin

-5%

Return on Equity

-122%

Return on Capital

-1%

Return on Assets

-100%

Earnings Yield

-23.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$30.60M

Shares Outstanding

368.68M

Volume

160

Avg. Volume

152.65K

Financials (TTM)

Gross Profit

$21.64K

Operating Income

$9.96M

EBITDA

$6.19M

Operating Cash Flow

$6.14M

Capital Expenditure

$787.67K

Free Cash Flow

$6.92M

Cash & ST Invst.

$4.52M

Total Debt

$2.38M

Bcal Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$42.62K

-97.7%

Gross Profit

$349.25K

-118.8%

Gross Margin

-8.19%

N/A

Market Cap

$30.60M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$3.92M

-62.8%

EBITDA

$4.63M

-17.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$445.76K

-112.7%

Accounts Receivable

$1.34M

+2.4%

Inventory

$0.00

N/A

Long Term Debt

$3.31M

+190.9%

Short Term Debt

$464.35K

+27.6%

Return on Assets

-99.81%

N/A

Return on Invested Capital

-1.34%

N/A

Free Cash Flow

$2.95M

-190.3%

Operating Cash Flow

$2.50M

-181.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EMD.AXEmyria Limited

EMD.AXEmyria Limited$0.05+0.00%

EYE.AXNova Eye Medical Limited

EYE.AXNova Eye Medical Limited$0.13-3.85%

IIQ.AXINOVIQ Ltd

IIQ.AXINOVIQ Ltd$0.33+0.00%

NOX.AXNoxopharm Limited

NOX.AXNoxopharm Limited$0.07+7.14%

HMD.AXHeraMED Limited

HMD.AXHeraMED Limited$0.05+6.52%

MAP.AXMicroba Life Sciences Limited

MAP.AXMicroba Life Sciences Limited$0.08+8.57%

AT1.AXAtomo Diagnostics Limited

AT1.AXAtomo Diagnostics Limited$0.02+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About BDX

What is the current price of Bcal Diagnostics?

Bcal Diagnostics is trading at A$0.08 per share.

What is the 52-week range for Bcal Diagnostics?

Over the past 52 weeks, Bcal Diagnostics has traded between A$0.05 and A$0.16.

How much debt does Bcal Diagnostics have?

As of the most recent reporting period, Bcal Diagnostics reported total debt of $2.38M.

How much cash does Bcal Diagnostics have on hand?

Bcal Diagnostics reported $4.52M in cash and cash equivalents in its most recent financial results.

What is Bcal Diagnostics’s dividend yield?

Bcal Diagnostics does not currently have a dividend yield.

Bcal Diagnostics

Bcal Diagnostics Financials at a Glance

BDX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bcal Diagnostics

BDX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bcal Diagnostics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BDX

What is the current price of Bcal Diagnostics?

What is the 52-week range for Bcal Diagnostics?

How much debt does Bcal Diagnostics have?

How much cash does Bcal Diagnostics have on hand?

What is Bcal Diagnostics’s dividend yield?

Premium Investing Services